Oaktree Acquisition Corp. III Life Sciences
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Oaktree Acquisition Corp. III Life Sciences now
Current reporting with the operating signal separated from the noise.
TradingView
Oaktree Acquisition Corp. III Life Sciences Revenue Breakdown – BOATS:OACCW
Investors are testing whether Oaktree Acquisition Corp. III Life Sciences’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest OACC filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2025-10-29 · Period 2025-10-29SEC ↗8-KMaterial company eventFiled 2025-10-17 · Period 2025-10-17SEC ↗8-KMaterial company eventFiled 2025-06-06 · Period 2025-06-03SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-05-15SEC ↗SCHEDULE 13GOfficial SEC filingFiled 2026-05-11SEC ↗
Oaktree Acquisition Corp. III Life Sciences, quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →